Member

András Tivadar KULJA

EPP · Hungary

Group: EPP PPE
Country: Hungary
Roll-call participation: 71.1 %ⓘ of 620 roll calls in office · chamber median 90.6 % · whole term, final votes
With majority line: 83.7 %ⓘ of 441 votes where the group had a line · EPP median 95.6 %

More facts (5)

National party: TISZA Tisztelet és Szabadság Párt
In office: Since 16 Jul 2024
Against clear line: 41 of 410 votesⓘ
Committees: ENVI (vice-chair), SANT
Member id: 256864

National party: TISZA Tisztelet és Szabadság Párt
In office: Since 16 Jul 2024
Against clear line: 41 of 410 votesⓘ
Committees: ENVI (vice-chair), SANT
Member id: 256864

Cite this page

EP profile

Link to this page

Record

The member’s figures against the median of their group and of the chamber. Each vote counts the member in the group they belonged to that day.

Period Whole term 2024 (from July)2025 2026

Custom dates

Votes Final votes620 All roll calls5 928

Roll-call participation ⓘ

71.1 %

441 of 620 final votes while in office

EPP median: 90.6 % (−19.4 pts)

Chamber median: 90.6 %

With majority line ⓘ

83.7 %

369 of 441 votes where their group had a line

EPP median: 95.6 % (−11.9 pts)

Against clear line ⓘ

10.0 %

41 of 410 votes where their group had a clear line

14 opposite (for ↔ against), 27 abstained against the line

Abstention ⓘ

8.8 %

39 of 441 votes cast

Participation 71.1 % — EPP median 90.6 %, 192 members.ⓘ

Data as a table

Participation among the 192 members of the EPP with enough votes.
Figure	Participation
András Tivadar KULJA	71.1 %
EPP median	90.6 %
Lowest in the group	18.4 %
Highest in the group	99.8 %
Members	192

With majority line 83.7 % — EPP median 95.6 %, 192 members.ⓘ

Data as a table

With majority line among the 192 members of the EPP with enough votes.
Figure	With majority line
András Tivadar KULJA	83.7 %
EPP median	95.6 %
Lowest in the group	67.8 %
Highest in the group	99.0 %
Members	192

Whole term, 620 final votes; 620 of 794 decisions had a final vote recorded by name. The dots are the other members of EPP; no ranks.
“No vote recorded” is not the same as absent: leave, illness and chairing the sitting look the same.
A group’s line is inferred from its members’ votes — Parliament publishes no whip.

Votes, 620

Export

Every final roll-call vote of the term with the member’s position, newest first.

Show Final votes All roll calls

Result: for–against–abstained. Majority line: how most of the member’s group voted that day (“Tie” when no position won). ≠ group marks a vote otherwise than a clear line (at least two thirds, with at least 10 members voting) of their group.
Date	Decision	Result	Position	Majority line
21 Jan 2026	Request for opinion from the Court of Justice on the compatibility with the Treaties of the proposed EU-Mercosur Partnership Agreement (EMPA) and Interim Trade Agreement (ITA)	Adopted 334 for, 324 against, 11 abstained	Position: For ≠ group	Majority line: Against
21 Jan 2026	Implementation of the common foreign and security policy – annual report 2025	Adopted 392 for, 179 against, 83 abstained	Position: No vote recorded	Majority line: For
21 Jan 2026	Implementation of the common security and defence policy – annual report 2025	Adopted 395 for, 197 against, 70 abstained	Position: No vote recorded	Majority line: For
21 Jan 2026	Human rights and democracy in the world and the European Union’s policy on the matter – annual report 2025	Adopted 421 for, 120 against, 108 abstained	Position: No vote recorded	Majority line: For
21 Jan 2026	Addressing impunity through EU sanctions, including the EU Global Human Rights sanctions regime (so-called ‘EU Magnitsky Act’)	Adopted 440 for, 127 against, 59 abstained	Position: No vote recorded	Majority line: For
20 Jan 2026	Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest	Passed 503 for, 57 against, 108 abstained	Position: For	Majority line: For
20 Jan 2026	The 28th Regime: a new legal framework for innovative companies	Adopted 492 for, 144 against, 28 abstained	Position: For	Majority line: For
20 Jan 2026	Just transition directive in the world of work: ensuring the creation of jobs and revitalising local economies	Adopted 420 for, 207 against, 20 abstained	Position: No vote recorded	Majority line: For
20 Jan 2026	Safeguarding and promoting financial stability amid economic uncertainties	Adopted 491 for, 83 against, 84 abstained	Position: For	Majority line: For
20 Jan 2026	Humanitarian aid in a time of polycrisis – reaffirming our principles for a more effective and ambitious response to humanitarian crises	Adopted 444 for, 153 against, 55 abstained	Position: No vote recorded	Majority line: For
20 Jan 2026	Reform of the European Electoral Act – hurdles to ratification and implementation in the Member States	Adopted 417 for, 234 against, 9 abstained	Position: For	Majority line: For
18 Dec 2025	Arbitrary arrest and sentencing of academics Bahruz Samadov and Igbal Abilov in Azerbaijan	Adopted 477 for, 7 against, 69 abstained	Position: For	Majority line: For
18 Dec 2025	Mass kidnapping of children in Nigeria, including from St Mary’s Catholic School in Papiri	Adopted 519 for, 2 against, 50 abstained	Position: For	Majority line: For
18 Dec 2025	Grave political situation in Guinea-Bissau after the coup of 26 November	Adopted 535 for, 0 against, 42 abstained	Position: For	Majority line: For
18 Dec 2025	Implementation of the rule of law conditionality regime	Adopted 386 for, 184 against, 15 abstained	Position: No vote recorded	Majority line: For
18 Dec 2025	Decarbonisation and modernisation of EU fisheries, and the development and deployment of fishing gear	Adopted 450 for, 93 against, 37 abstained	Position: For	Majority line: For
18 Dec 2025	Continuous Belarusian hybrid attacks against Lithuania	Adopted 438 for, 37 against, 48 abstained	Position: For	Majority line: For
17 Dec 2025	Application of the ‘safe third country’ concept	Negotiating mandate approved 384 for, 237 against, 31 abstained	Position: No vote recorded	Majority line: For
17 Dec 2025	Establishment of a list of safe countries of origin at Union level	Negotiating mandate approved 396 for, 202 against, 56 abstained	Position: No vote recorded	Majority line: For
17 Dec 2025	Phasing out Russian natural gas imports, improving monitoring of potential energy dependencies	Passed 500 for, 120 against, 32 abstained	Position: No vote recorded	Majority line: For
17 Dec 2025	Deforestation Regulation: certain obligations of operators and traders	Passed 405 for, 242 against, 8 abstained	Position: No vote recorded	Majority line: For
17 Dec 2025	European High Performance Computing Joint Undertaking (EuroHPC)	Passed 604 for, 37 against, 18 abstained	Position: No vote recorded	Majority line: For
17 Dec 2025	EU/Jordan Agreement for scientific and technological cooperation: terms and conditions for the participation of Jordan in the Partnership for Research and Innovation in the Mediterranean Area (PRIMA)	Consent given 627 for, 13 against, 5 abstained	Position: No vote recorded	Majority line: For
17 Dec 2025	Simplification of the content and presentation of information to be disclosed concerning environmentally sustainable activities and simplification of certain technical screening criteria for determining whether economic activities cause no significant harm to environmental objectives	Objection failed 230 for, 402 against, 28 abstained	Position: No vote recorded	Majority line: Against
17 Dec 2025	Military Mobility	Adopted 493 for, 127 against, 38 abstained	Position: No vote recorded	Majority line: For
17 Dec 2025	European Defence Readiness 2030: assessment of needs	Adopted 425 for, 120 against, 96 abstained	Position: No vote recorded	Majority line: For
17 Dec 2025	Digitalisation, artificial intelligence and algorithmic management in the workplace – shaping the future of work	Adopted 480 for, 83 against, 94 abstained	Position: No vote recorded	Majority line: For
17 Dec 2025	European Citizens’ Initiative ‘My voice, my choice: for safe and accessible abortion’	Adopted 358 for, 202 against, 79 abstained	Position: No vote recorded	Majority line: For
16 Dec 2025	Bilateral safeguard clause of the EU-Mercosur Partnership Agreement and the EU-Mercosur Interim Trade Agreement for agricultural products	Passed 431 for, 161 against, 70 abstained	Position: No vote recorded	Majority line: For
16 Dec 2025	Amending the Directive on alternative dispute resolution for consumer disputes	Amendment 1 rejected 122 for, 470 against, 69 abstained	Position: Against	Majority line: Against
16 Dec 2025	Incentivising defence-related investments in the EU budget to implement the ReArm Europe Plan	Passed 519 for, 119 against, 25 abstained	Position: For	Majority line: For
16 Dec 2025	Amending certain CAP Regulations as regards the conditionality system, types of intervention in the form of direct payment, types of intervention in certain sectors and rural development and annual performance reports, data and interoperability governance, suspensions of payments annual performance clearance and controls and penalties	Passed 629 for, 17 against, 16 abstained	Position: For	Majority line: For
16 Dec 2025	Providing macro-financial assistance to Jordan	Passed 585 for, 34 against, 45 abstained	Position: For	Majority line: For
16 Dec 2025	Brexit Adjustment Reserve	Passed 619 for, 6 against, 37 abstained	Position: For	Majority line: For
16 Dec 2025	Corporate sustainability reporting and due diligence requirements	Passed 428 for, 218 against, 17 abstained	Position: For	Majority line: For
16 Dec 2025	Mobilisation of the European Globalisation Adjustment Fund for Displaced Workers: application EGF/2025/003 SE/Northvolt – Sweden	Passed 578 for, 54 against, 30 abstained	Position: For	Majority line: For
16 Dec 2025	Genetically modified maize NK603	Objection passed 479 for, 173 against, 8 abstained	Position: For	Majority line: Against
16 Dec 2025	Genetically modified sugar beet KWS20-1	Objection passed 455 for, 169 against, 8 abstained	Position: For	Majority line: Against
16 Dec 2025	Relations between the EU and Saudi Arabia	Adopted 417 for, 131 against, 108 abstained	Position: For	Majority line: For
27 Nov 2025	Amending Regulations on the Internal Market Information System (IMI) and on the single digital gateway as regards certain harmonisation requirements on transparency	Passed 400 for, 77 against, 132 abstained	Position: For	Majority line: For
27 Nov 2025	Harmonised requirements in the internal market on transparency of third countries interest representation	Passed 392 for, 88 against, 133 abstained	Position: For	Majority line: For
27 Nov 2025	Post-election killings and the deteriorating human rights situation in Tanzania, including the case of imprisoned opposition leader Tundu Lissu	Adopted 539 for, 0 against, 27 abstained	Position: For	Majority line: For
27 Nov 2025	Escalating repression of the Baha’is in Iran	Adopted 549 for, 7 against, 31 abstained	Position: For	Majority line: For
27 Nov 2025	Rule of law and human rights situation in Tunisia, particularly the case of Sonia Dahmani	Adopted 464 for, 58 against, 75 abstained	Position: For	Majority line: For
27 Nov 2025	Implementation of the EU-UK Trade and Cooperation Agreement	Adopted 490 for, 41 against, 74 abstained	Position: No vote recorded	Majority line: For
27 Nov 2025	EU strategy for the rights of persons with disabilities post-2024	Adopted 490 for, 9 against, 109 abstained	Position: For	Majority line: For
27 Nov 2025	Application of the Treaty provisions related to the principles of subsidiarity and proportionality and the role of national parliaments in the EU legislative process	Adopted 337 for, 245 against, 12 abstained	Position: For	Majority line: For
27 Nov 2025	Escalation of the war and the humanitarian catastrophe in Sudan	Adopted 503 for, 32 against, 52 abstained	Position: For	Majority line: For
27 Nov 2025	Political situation in Myanmar including the humanitarian crisis of the Rohingya	Adopted 519 for, 3 against, 57 abstained	Position: For	Majority line: For
27 Nov 2025	EU position on the proposed plan and EU engagement towards a just and lasting peace for Ukraine	Adopted 401 for, 70 against, 90 abstained	Position: No vote recorded	Majority line: For

Show all 50 votes on this page

Roll-call participation

One cell per sitting while in office, shaded by the share of that day’s roll calls the member voted in. The official attendance register is kept separately by Parliament.

No vote recorded on 14 of 80 sittings with roll calls.

"No vote recorded" is not the same as absent: leave, illness and chairing the sitting look the same.

Data as a table

Roll calls held at each sitting while in office and how many of them the member voted in.
Sitting	Roll calls	Voted in
17 Jul 2024	1	1
18 Sept 2024	2	2
19 Sept 2024	6	6
8 Oct 2024	1	1
9 Oct 2024	2	2
10 Oct 2024	1	1
22 Oct 2024	5	5
23 Oct 2024	2	2
24 Oct 2024	2	2
14 Nov 2024	5	5
26 Nov 2024	8	8
27 Nov 2024	7	7
28 Nov 2024	6	0
17 Dec 2024	6	6
18 Dec 2024	7	7
19 Dec 2024	5	4
21 Jan 2025	1	1
22 Jan 2025	1	1
23 Jan 2025	4	4
11 Feb 2025	4	4
12 Feb 2025	4	4
13 Feb 2025	2	2
11 Mar 2025	4	0
12 Mar 2025	7	4
13 Mar 2025	3	2
1 Apr 2025	7	7
2 Apr 2025	9	5
3 Apr 2025	5	5
6 May 2025	4	2
7 May 2025	20	20
8 May 2025	12	11
22 May 2025	6	4
17 Jun 2025	8	0
18 Jun 2025	7	0
19 Jun 2025	6	0
8 Jul 2025	8	7
9 Jul 2025	14	12
10 Jul 2025	7	6
9 Sept 2025	6	5
10 Sept 2025	15	13
11 Sept 2025	8	6
7 Oct 2025	4	4
8 Oct 2025	10	7
9 Oct 2025	10	8
21 Oct 2025	8	8
22 Oct 2025	6	3
23 Oct 2025	5	0
13 Nov 2025	16	14
25 Nov 2025	13	7
26 Nov 2025	10	9
27 Nov 2025	11	9
16 Dec 2025	11	10
17 Dec 2025	11	0
18 Dec 2025	6	5
20 Jan 2026	6	4
21 Jan 2026	8	4
22 Jan 2026	8	0
10 Feb 2026	8	8
11 Feb 2026	10	9
12 Feb 2026	8	0
24 Feb 2026	1	0
10 Mar 2026	9	0
11 Mar 2026	12	0
12 Mar 2026	6	0
26 Mar 2026	13	1
28 Apr 2026	14	0
29 Apr 2026	17	14
30 Apr 2026	11	9
19 May 2026	3	3
20 May 2026	12	12
21 May 2026	10	10
16 Jun 2026	10	9
17 Jun 2026	16	15
18 Jun 2026	7	6
7 Jul 2026	15	14
8 Jul 2026	15	14
9 Jul 2026	4	4
15 Sept 2026	12	11
16 Sept 2026	16	16
17 Sept 2026	10	10

Voting neighbours

Members who voted the same way most often in the roll calls they both took part in, within and outside the member’s group (group at the date of each vote), over all roll calls of the term.

At least 200 shared roll calls over at least six months in office together. Within = both sat in the same group on the date of the vote; a member who changed group can appear on both lists. Baseline = the median agreement of all pairs of members of the groups the two sat in on the date of each shared vote (within: the group they shared; outside: the two groups), weighted by the votes they shared in each combination.

Within EPP

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in the same group (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of that group.
Select	Member	Group	Country	Agreement	Baseline
Select Eszter LAKOS	Eszter LAKOS	EPP	Hungary	99 % of 3 274 shared	89 %
Select Dóra DÁVID	Dóra DÁVID	EPP	Hungary	99 % of 3 586 shared	89 %
Select Gabriella GERZSENYI	Gabriella GERZSENYI	EPP	Hungary	99 % of 2 356 shared	89 %
Select Kinga KOLLÁR	Kinga KOLLÁR	EPP	Hungary	99 % of 3 067 shared	89 %
Select Zoltán TARR	Zoltán TARR Former member	EPP	Hungary	97 % of 1 796 shared	89 %
Select Péter MAGYAR	Péter MAGYAR Former member	EPP	Hungary	93 % of 682 shared	89 %
Select Willemien KONING	Willemien KONING	EPP	Netherlands	89 % of 1 213 shared	89 %
Select Marie-Sophie CHRIST	Marie-Sophie CHRIST	EPP	Germany	88 % of 1 291 shared	89 %
Select Manfred WEBER	Manfred WEBER	EPP	Germany	88 % of 2 850 shared	89 %
Select Martine KEMP	Martine KEMP	EPP	Luxembourg	87 % of 2 916 shared	89 %

Show all 10 neighbours

Outside the group

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in different groups (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of the groups the two sat in on those votes (groups at the date, weighted by the votes shared in each combination).
Select	Member	Group	Country	Agreement	Baseline
Select Jérémy DECERLE	Jérémy DECERLE	Renew	France	79 % of 1 750 shared	82 %
Select Ivars IJABS	Ivars IJABS	Renew	Latvia	78 % of 2 812 shared	82 %
Select Sophie WILMÈS	Sophie WILMÈS	Renew	Belgium	78 % of 2 466 shared	82 %
Select Urmas PAET	Urmas PAET	Renew	Estonia	78 % of 3 122 shared	82 %
Select Hilde VAUTMANS	Hilde VAUTMANS	Renew	Belgium	78 % of 3 514 shared	82 %
Select Nathalie LOISEAU	Nathalie LOISEAU	Renew	France	78 % of 2 822 shared	82 %
Select Eugen TOMAC	Eugen TOMAC	Renew	Romania	77 % of 2 398 shared	82 %
Select Gilles BOYER	Gilles BOYER	Renew	France	77 % of 3 612 shared	82 %
Select Benoit CASSART	Benoit CASSART	Renew	Belgium	77 % of 3 409 shared	82 %
Select Grégory ALLIONE	Grégory ALLIONE	Renew	France	77 % of 3 203 shared	82 %

Show all 10 neighbours

Work

Seats in committees, delegations and intergroups, and the dossiers the member leads, shadows or negotiates.

Seats

Body: the committee, delegation or intergroup, with its kind. Role: the member’s role in it. From, To: the dates of the seat (“now” while it lasts).
Body	Role	From	To
Committee on the Environment, Climate and Food SafetyENVI Committee	Vice-chair	20 Jan 2025	now
Committee on Public HealthSANT Committee	Member	23 Jan 2025	now
Delegation for relations with CanadaD-CA Delegation	Substitute	12 Jun 2026	now
Delegation for relations with the Korean PeninsulaDKOR Delegation	Substitute	19 Sept 2024	now
Intergroup on Anti-CorruptionIG10-01 Intergroup / working group	Member	16 Jan 2025	now
Intergroup on Cancer and Rare DiseasesIG10-05 Intergroup / working group	Member	27 Jan 2025	now
Intergroup on DisabilityIG10-10 Intergroup / working group	Member	11 Mar 2025	now
Intergroup on Mental HealthIG10-17 Intergroup / working group	Member	5 Feb 2025	now
Intergroup on Traditional Minorities, National Communities and LanguagesIG10-25 Intergroup / working group	Member	5 Feb 2025	now
Committee on Employment and Social AffairsEMPL Committee	Substitute	19 Jul 2024	11 Jun 2026

Show all 13 seats

Dossiers

Dossier: the procedure the declaration names (“No dossier named” for a delegation without one). Role: rapporteur, shadow rapporteur, negotiator or delegation. Committee: the committee that appointed them. Date: of the declaration.
Dossier	Role	Committee	Date
No dossier named	Official delegation	SANT	2 Sept 2026
No dossier named	Official delegation	SANT	22 Apr 2026
No dossier named	Official delegation	SANT	29 Jan 2026
An EU health workforce crisis plan: sustainability of healthcare systems and employment and working conditions in the healthcare sector	Shadow rapporteur	SANT	8 Oct 2025
Laying a framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest, and amending Regulation (EU) 2024/795	Shadow rapporteur for an opinion	ENVI	19 Jun 2025
No dossier named	Official delegation	ENVI	17 Mar 2025
Implementation and delivery of the Sustainable Development Goals in view of the 2025 High-Level Political Forum	Shadow rapporteur	ENVI	24 Feb 2025
Safety of toys	Shadow rapporteur for an opinion	ENVI	14 Nov 2024
No dossier named	Official delegation		25 Oct 2024
No dossier named	Official delegation		11 Sept 2024

Show all 11 dossier roles

Topics they work on (model-assigned)

Counts: dossiers they spoke on, led or amended, and their questions and motions.

In the chamber

Speeches and statements in plenary debates, newest first; the verbatim report is on Parliament’s site.

38 contributions recorded, 2 written statements; 4 on behalf of their group; 52 minutes of speaking time.

Date: the sitting. Debate: the item debated, and the group when they spoke on its behalf. Kind: speech or written statement, with speaking time. Verbatim: the verbatim report on Parliament’s site.
Date	Debate	Kind	Verbatim
17 Sept 2026	Protecting people’s health against toxic substances (debate)	Speech · 1 min	Read
17 Sept 2026	An EU health workforce crisis plan: sustainability of healthcare systems and employment and working conditions in the healthcare sector (debate) on behalf of EPP	Speech · 2 min	Read
15 Sept 2026	Findings and recommendations of the Special Committee on the European Democracy Shield (debate)	Speech · 1 min	Read
15 Sept 2026	Devastating heatwaves, wildfires and droughts in Europe: lessons from summer 2026 (debate)	Speech · 1 min	Read
11 Feb 2026	Rule of law, fundamental rights and misuse of EU funds in Slovakia: the need for an EU response (debate)	Speech · 1 min	Read
19 Jan 2026	Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest (debate) on behalf of EPP	Speech · 2 min	Read
16 Dec 2025	Presentation of the EU Cardiovascular Health Plan (debate)	Speech · 1 min	Read
16 Dec 2025	Presentation of the EU Cardiovascular Health Plan (debate)	Speech · 2 min	Read
15 Dec 2025	Impact of the geopolitical situation on European patients and their access to medicines (debate)	Speech · 2 min	Read
23 Oct 2025	Breast cancer: the importance of screening (debate)	Statement	Read

Show all 38 recent contributions

Questions and motions, 14

Parliamentary questions and motions for resolutions the member authored or co-signed, newest first.

Date: tabled. Title: the question or motion, with its id. Kind: written question or motion for a resolution, with the number of co-authors. Answer: the date of the answer to a question.
Date	Title	Kind	Answer
18 May 2026	Access to reliable clinical performance data and regulatory oversight of CGM systems in the EU E-10-2026-002029	Written question	17 Jul 2026
11 Feb 2026	Request for an assessment of land confiscation practices and of the criminalisation of public criticism of historical legislation in Slovakia P-10-2026-000603	Priority written questionwith 6 co-authors	30 Apr 2026
22 Dec 2025	Serious concerns regarding compliance with European values and EU law in Slovakia E-10-2025-005054	Written questionwith 12 co-authors	21 Apr 2026
20 Dec 2025	Implementation of EU anti-poverty strategy based on accurate data E-10-2025-005037	Written questionwith 5 co-authors	25 Feb 2026
23 Sept 2025	Newborn screening for access to advanced life-saving therapies E-10-2025-003675	Written questionwith 3 co-authors	21 Nov 2025
17 Jun 2025	The role of local authorities in addressing the financial and operational challenges posed by PFAS and other persistent chemical contaminants in Europe E-10-2025-002429	Written questionwith 20 co-authors	26 Aug 2025
29 Apr 2025	Strengthening workplace health and safety to prevent sudden cardiac arrest deaths E-10-2025-001716	Written question	13 Jun 2025
26 Feb 2025	Rare diseases P-10-2025-000845	Priority written questionwith 7 co-authors	2 May 2025
21 Feb 2025	Commission’s response to the incomplete implementation of the UN Convention on the Rights of Persons with Disabilities in Member States E-10-2025-000810	Written questionwith 50 co-authors	27 May 2025
20 Jan 2025	Infection prevention and action against antimicrobial resistance, including innovative therapies E-10-2025-000213	Written question	18 Mar 2025
6 Jan 2025	Need for diversified, sustainable pain management in the EU to reduce reliance on pharmaceuticals and strengthen supply chains, thus enhancing sustainable healthcare E-10-2025-000010	Written question	29 Apr 2025
12 Dec 2024	Understaffing of healthcare professionals in EU public health systems E-10-2024-002877	Written question	24 Feb 2025
20 Nov 2024	Universal health coverage – global health challenges E-10-2024-002589	Written question	30 Jan 2025
17 Sept 2024	MOTION FOR A RESOLUTION on the devastating floods in central and eastern Europe, the loss of lives and the EU’s preparedness to act on such disasters exacerbated by climate change B-10-2024-0057	Motion for a resolutionwith 24 co-authors	—

Amendments tabled in committee, 52

Committee amendment documents that carry amendments by the member, with how many are theirs.

Date: of the amendment document. Text amended: the dossier and the document’s id. Committee: where the amendments were tabled. Amendments: how many in the document are the member’s.
Date	Text amended	Committee	Amendments
11 Sept 2026	Modernised rules for patients’ rights in cross-border healthcare SANT-AM-792014	SANT	26
11 Sept 2026	Modernised rules for patients’ rights in cross-border healthcare SANT-AM-792154	SANT	5
28 Jul 2026	Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791891	SANT	3
28 Jul 2026	Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791887	SANT	9
28 Jul 2026	Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791890	SANT	1
13 Jul 2026	Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790936	CJ53	5
13 Jul 2026	Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790937	CJ53	9
13 Jul 2026	Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790938	CJ53	1
13 Jul 2026	Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790939	CJ53	6
13 Jul 2026	Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790934	CJ53	6

Show all 52 amendment documents

Connections

Dossiers they lead or shadow, committees, party, delegation and other related pages.

Political group

Group European People’s Party EPP · Centre-right · Christian democracy, conservatism

National delegation

Delegation Hungary National delegation

Sources & citation

Where the facts on this page come from, and how to cite it.

Permalink: https://news.eu-parl.st-solutions.dev/members/256864?docs=all&page=6&scope=final
Official source: Member’s profile, European Parliament
Data source: EP Open Data: member record
Licensed CC BY 4.0.
Data version: data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1 · methods
Retrieved: 25 September 2026

Cite as

EU Parl Watch Research (2026). “András Tivadar KULJA”. Member record. memberId 256864. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/members/256864?docs=all&page=6&scope=final (retrieved 25 September 2026). Official source: Member’s profile, European Parliament, https://www.europarl.europa.eu/meps/en/256864. Data: EP Open Data: member record, https://data.europarl.europa.eu/api/v2/meps/256864?format=application%2Fld%2Bjson (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1.

BibTeX

@misc{epw-member-256864,
  author = {{EU Parl Watch Research}},
  title = {{András Tivadar KULJA}},
  year = {2026},
  howpublished = {\url{https://news.eu-parl.st-solutions.dev/members/256864?docs=all&page=6&scope=final}},
  url = {https://news.eu-parl.st-solutions.dev/members/256864?docs=all&page=6&scope=final},
  urldate = {2026-09-25},
  publisher = {EU Parl Watch Research},
  note = {Member record. memberId 256864. Official source: https://www.europarl.europa.eu/meps/en/256864. Data: EP Open Data: member record (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1}
}